zh-twzhen
zh-twzhen

NEWS

合一生技股份有限公司 / 2023 / An European patent titled “USE OF FLAVONOID COMPOUND IN PREPARATION OF COMPOSITION FOR HEALING WOUND” has been granted.

An European patent titled “USE OF FLAVONOID COMPOUND IN PREPARATION OF COMPOSITION FOR HEALING WOUND” has been granted.

2023-11-29

Published Date:2023-11-29

Original Link:https://www.onenessbio.com/en/news_detail251_1.htm

No 1 Date of announcement 2023/11/29 Time of announcement 17:01:08
Subject An European patent titled “USE OF FLAVONOID COMPOUND IN PREPARATION OF COMPOSITION FOR HEALING WOUND” has been granted.
To which item it meets paragraph 53 Date of events 2023/11/29
Statement
  1. Date of occurrence of the event:2023/11/29
  2. Company name:ONENESS BIOTECH CO., LTD.
  3. Relationship to the Company (please enter “head office” or  “subsidiaries”):head office
  4. Reciprocal shareholding ratios:NA
  5. Cause of occurrence:The Company has been informed by the patent agency that an European patent titled “USE OF FLAVONOID COMPOUND IN PREPARATION OF COMPOSITION FOR HEALING WOUND” has been granted under the patent number EP3189837.
  6. Countermeasures:None
  7. Any other matters that need to be specified(the information disclosure also meets the requirements of Article 7, subparagraph 9 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.):
    This patent is to protect the active compound in Fespixon cream (Research code: ON101), which is part of global patent protection of Fespixon cream.
    No manufacturing of the active compound of Plectranthus amboinicus will be allowed.